Puig L - Search Results

1

[Guidelines on the use of methotrexate in psoriasis].

Carretero G, Puig L, Dehesa L, Carrascosa JM, Ribera M, Sánchez-Regaña M, Daudén E, Vidal D, Alsina M, Muñoz-Santos C, López-Estebaranz JL, Notario J, Ferrandiz C, Vanaclocha F, García-Bustinduy M, Taberner R, Belinchón I, Sánchez-Carazo J, Moreno JC; Grupo de Psoriasis de la AEDV. Carretero G, et al. Among authors: puig l. Actas Dermosifiliogr. 2010 Sep;101(7):600-13. Actas Dermosifiliogr. 2010. PMID: 20858386 Spanish.

2

Epidermal expression of 65 and 72 kd heat shock proteins in psoriasis and AIDS-associated psoriasiform dermatitis.

Puig L, Fernández-Figueras MT, Ferrándiz C, Ribera M, de Moragas JM. Puig L, et al. J Am Acad Dermatol. 1995 Dec;33(6):985-9. doi: 10.1016/0190-9622(95)90291-0. J Am Acad Dermatol. 1995. PMID: 7490370

3

Sti571-induced Stevens-Johnson Syndrome.

Vidal D, Puig L, Sureda A, Alomar A. Vidal D, et al. Among authors: puig l. Br J Haematol. 2002 Oct;119(1):274-5. doi: 10.1046/j.1365-2141.2002.37133.x. Br J Haematol. 2002. PMID: 12358937 Free article. No abstract available.

4

Acute generalized exanthematous pustulosis induced by terbinafine.

Taberner R, Puig L, Gilaberte M, Alomar A. Taberner R, et al. Among authors: puig l. Eur J Dermatol. 2003 May-Jun;13(3):313-4. Eur J Dermatol. 2003. PMID: 12805000 Review.

5

Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features.

Vidal D, Puig L, Gilaberte M, Alomar A. Vidal D, et al. Among authors: puig l. J Dermatolog Treat. 2004 Jun;15(3):146-52. doi: 10.1080/09546630410031909. J Dermatolog Treat. 2004. PMID: 15204146 Free article.

6

Adverse cutaneous reactions to anakinra in patients with rheumatoid arthritis: clinicopathological study of five patients.

Vila AT, Puig L, Fernández-Figueras MT, Laiz AM, Vidal D, Alomar A. Vila AT, et al. Among authors: puig l. Br J Dermatol. 2005 Aug;153(2):417-23. doi: 10.1111/j.1365-2133.2005.06635.x. Br J Dermatol. 2005. PMID: 16086759

7

[Validation of the Spanish version of the Psoriasis Disability Index questionnaire in assessing the quality of life of patients with moderate-severe psoriasis].

Vanaclocha F, Puig L, Daudén E, Escudero J, Hernanz JM, Ferrándiz C, Febrer I, Lizán L, Badia X. Vanaclocha F, et al. Among authors: puig l. Actas Dermosifiliogr. 2005 Dec;96(10):659-68. doi: 10.1016/s0001-7310(05)73154-9. Actas Dermosifiliogr. 2005. PMID: 16476316 Free article. Spanish.

8

[Which patient is a candidate for treatment with efalizumab and why?].

Puig L. Puig L. Actas Dermosifiliogr. 2008 Jan;99 Suppl 1:51-61. doi: 10.1016/s0001-7310(08)76198-2. Actas Dermosifiliogr. 2008. PMID: 18341853 Free article. Review. Spanish.

9

[Infliximab: patients selection].

Puig L. Puig L. Actas Dermosifiliogr. 2008 Jul;99 Suppl 4:23-9. Actas Dermosifiliogr. 2008. PMID: 19080988 Free article. Spanish.

10

[Efficacy of treatment with infliximab in patients with moderate-severe psoriasis and high needs of therapy. A retrospective study of 43 patients].

Puig L. Puig L. Actas Dermosifiliogr. 2008 Jul;99 Suppl 4:30-5. Actas Dermosifiliogr. 2008. PMID: 19080989 Free article. Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

807 results

Search Page

Filters